| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 29 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $21.70M | - | |
| 10% | 5.61M | $11.79M | - | |
| CFO | 100.0K | $210.0K | - | |
| CEO | 100.0K | $210.0K | - | |
| Other | 100.0K | $210.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | 10x Fund, L.P.85 | 10% Owner | Sell | 30,681 | $6.66 | $204,335.46 | -0.5% | -48.7% | - | |
| Dec 15, 2025 | Shlevin Harold H.89 | Director | Sale+OE | 28,210 | $6.28 | $177,208.38 | -55.7% | -51.2% | - | |
| Dec 9, 2025 | Shlevin Harold H.89 | Director | Sale+OE | 175,790 | $6.00 | $1,055,311.14 | -66.2% | -43.7% | - | |
| Dec 3, 2025 | 10x Fund, L.P.85 | 10% Owner | Sell | 150,000 | $5.68 | $851,700.00 | -1.3% | -47.7% | - | |
| Nov 18, 2025 | Lewis Joel59 | President And CEO | Sale+OE | 22,463 | $6.07 | $136,365.82 | -1.3% | -55.7% | - | |
| Nov 18, 2025 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 77,920 | $6.15 | $478,849.17 | -67.2% | -55.7% | - | |
| Nov 13, 2025 | Jamil Khurram | Chief Medical Officer | Sale+OE | 121,117 | $5.47 | $662,509.99 | -87.1% | -50.1% | - | |
| Nov 11, 2025 | 10x Fund, L.P.85 | 10% Owner | Sell | 40,000 | $5.25 | $210,000.00 | -0.7% | -50.5% | - | |
| Nov 10, 2025 | Lewis Joel59 | President And CEO | Sale+OE | 1,867 | $6.03 | $11,252.22 | -0.2% | -47.7% | - | |
| Nov 10, 2025 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 5,291 | $6.03 | $31,883.65 | -18.8% | -47.7% | - |